Evaluation the Relationship between Oral Contraceptives Containing Drospirenone with Dyslipidemia and Risk of Cardiovascular Diseases among Women in Al-kut City

Authors

  • Haider Hafudh Humaish1 , Amer Alasadi2 ,Intithar Aldafae3

DOI:

https://doi.org/10.37506/ijfmt.v14i4.11827

Keywords:

oral contraceptive, lipid profile, cardiovascular disease, leptin, CK-MB.

Abstract

Chronic and prolong use of oral contraceptives (OCs) may lead to appearance of undesirable effects in
women who used these drugs. There are many types of contraceptives, some contain estrogen and the other
contain progesterone, or combination of them in the same drug. This work was performed in a population of
adult females to study the relationship between the chronic use of OCs with dyslipidemia and the threat of
cardiac diseases. A total 163 volunteers were participated in this study, and, their aged between 21-42 years
old. In addition, all women were free of heart disease, dyslipidemia and any hormonal disturbance according
to their health records. They were categorized into three differnt groups, the control group included 52
unmarried women and does not use any OCs, group A: included 57 women took OCs (combination pill
estrogen and progestin) for less than 6 months, and group B contained 54 women used OCs for more than one
year. We meassued lipid profile, and blood indices of cardiovascular disease, like Creatine Kinase-MB (CKMB), insulin, Lactate Dehydrogenase (LDH) albumin, leptin and HbA1c test. In addition, we determined the
coronary risk index, atherogenic Coefficient, and an atherogenic index . Our results recorded a significant
increase in total cholesterol, LDL, coronary risk index (TC/HDL), LDH and HbA1c in group2 compared
to compared to control group. Furthermore, our data demonstrated no clear differences in Triglyceride,
leptin hormone, TG, HDL, insulin, albumin and CK-MB in group2 compared to control. Moreover, the
data indicated a significant elevation in the concentration of leptin hormone, LDH, HbA1c, TC, TG, LDL,
coronary risk index , atherogenic Coefficient and Atherogenic index, and significant decline in HDL and
albumin in group B compared with control group. Therefore, we concluded that oral contraceptive could
deter the lipid profile status and some enzyme related to the cardiovascular system. These alterations convey
a possible risk for the development of cardiac diseases. Routine screeing of lipid tests would be measured in
women used OCs for long periods to avoid any potential risk of cardiac diseases.

Author Biography

  • Haider Hafudh Humaish1 , Amer Alasadi2 ,Intithar Aldafae3

    1Assistant Prof, Department of pathological analysis, Technical institute / kut / Middle technical university/Iraq,
    2Lecture, Department of Medical Basic Sciences, College of Nursing, University of Thi-Qar/Iraq,
    3Specialist Physician, pediatrician/ Al - Kut Cooperative Hospital for Women and Children/Iraq

Downloads

Published

2020-10-29

How to Cite

Evaluation the Relationship between Oral Contraceptives Containing Drospirenone with Dyslipidemia and Risk of Cardiovascular Diseases among Women in Al-kut City. (2020). Indian Journal of Forensic Medicine & Toxicology, 14(4), 1920-1926. https://doi.org/10.37506/ijfmt.v14i4.11827